Platelet Lysates Advancing Cell-based Medicine
Sandra Mjoll Jonsdottir, EUWIIN Award 2017 Winner, is a biomedical scientist and the co-founder of Platome Biotechnology, a biotech startup that she leads as the CEO.
Sandra, and her team, have for the past few years been involved in the development of technology that aims to accelerate and advance cell based medicine. This technology focuses on using waste blood platelets from blood banks to create nutritional supplements for stem cells. These supplements are a valuable addition to methods in the field and allow scientists to study and grow stem cells without the need for animal derived products.
Platome develops a range of solutions and products. The products are called platelet lysates and can be used directly to grow cells. Since the platelet lysates are free of animal protein they comply with current regulations and are safe for human cells. By using platelet lysates for their cells, scientists save time, effort and increase the quality of their research. The team behind Platome has developed a novel way to produce such solutions and is in the process of filing for patents. To gain further information, please check: www.platome.com